OCM
JNJ icon

Oakview Capital Management’s Johnson & Johnson JNJ Stock Holding History

Oakview Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-250
Closed -$31K – 17
2017
Q1 		$31K Hold
250
– – 0.01% 30
2016
Q4 		$29K Buy
+250
New +$28.9K 0.02% 29

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oakview Capital Management's JNJ Position: Q2 2017 in Review

Oakview Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2017, closing a stake of 250 shares — an estimated $31K sold.

Oakview Capital Management first reported a position in JNJ in Q4 2016 and held it in 2 quarters. The position peaked at $31K in Q1 2017. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.

  • Oakview Capital Management reported no remaining Johnson & Johnson position as of Q2 2017 after selling out during the quarter.
  • Oakview Capital Management sold 250 Johnson & Johnson shares in Q2 2017, an estimated $31K.
  • Oakview Capital Management first reported a position in Johnson & Johnson in Q4 2016 and held it in 2 quarters.
  • Oakview Capital Management's Johnson & Johnson position peaked at $31K in Q1 2017.
  • 2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.

Based on Oakview Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.